RIP3 A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator
The present invention relates to an anti-cancer adjuvant pharmaceutical composition and an anti-cancer pharmaceutical composition for enhancing reactivity to anti-cancer drugs, which contain a receptor-interacting protein kinase-3 (RIP3) expression accelerator or activator as an active component. In...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!